Revance Therapeutics (RVNC)
(Real Time Quote from BATS)
$5.36 USD
-0.14 (-2.46%)
Updated Sep 25, 2024 02:46 PM ET
2-Buy of 5 2
D Value B Growth NA Momentum NA VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | 25.00% |
ABR | 2.78 |
Earnings ESP
|
0.00% |
---|---|
Current Year | NA |
Next Year | -0.46 |
EPS (TTM) | -2.26 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 67.73M | 84.44M | 269.52M | 359.02M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 68.00M | 86.40M | 271.70M | 404.03M |
Low Estimate | 67.20M | 81.10M | 266.50M | 319.20M |
Year ago Sales | 56.78M | 69.80M | 234.04M | 269.52M |
Year over Year Growth Est. | 19.29% | 20.97% | 15.16% | 33.21% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.28 | NA | -0.46 |
# of Estimates | 1 | 1 | NA | 1 |
Most Recent Consensus | -0.35 | -0.28 | NA | -0.46 |
High Estimate | -0.35 | -0.28 | NA | -0.46 |
Low Estimate | -0.35 | -0.28 | NA | -0.46 |
Year ago EPS | -0.74 | -0.62 | -3.83 | NA |
Year over Year Growth Est. | 52.70% | 54.84% | NA | NA |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | NA | 0 |
Up Last 30 Days | 0 | 0 | NA | 0 |
Up Last 60 Days | 1 | 1 | NA | 1 |
Down Last 7 Days | 0 | 0 | NA | 0 |
Down Last 30 Days | 0 | 0 | NA | 0 |
Down Last 60 Days | 0 | 0 | NA | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.28 | NA | -0.46 |
7 Days Ago | -0.35 | -0.28 | NA | -0.46 |
30 Days Ago | -0.36 | -0.31 | -1.57 | -0.62 |
60 Days Ago | -0.34 | -0.29 | -1.40 | -0.62 |
90 Days Ago | -0.34 | -0.29 | -1.40 | -0.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.28 | NA | -0.46 |
Zacks Consensus Estimate | -0.35 | -0.28 | NA | -0.46 |
Earnings ESP | 0.00% | 0.00% | NA | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.54 | -0.62 | -0.74 | NA |
Estimate | -0.48 | -0.66 | -0.79 | -1.02 | NA |
Difference | 0.12 | 0.12 | 0.17 | 0.28 | 0.17 |
Surprise | 25.00% | 18.18% | 21.52% | 27.45% | 23.04% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more